Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in Adults

ClinicalTrials.gov ID: NCT03342898

Public ClinicalTrials.gov record NCT03342898. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Observer-Blind, Placebo-Controlled, Phase 3 Trial to Investigate the Immunogenicity and Safety of a Tetravalent Dengue Vaccine Candidate and a Yellow Fever YF-17D Vaccine Administered Concomitantly and Sequentially in Healthy Subjects Aged 18 to 60 Years in Non-Endemic Country(Ies)

Study identification

NCT ID
NCT03342898
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
900 participants

Conditions and interventions

Conditions

Interventions

  • YF-17D Biological
  • TDV Biological
  • Placebo Drug

Biological · Drug

Eligibility (public fields only)

Age range
18 Years to 60 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 27, 2018
Primary completion
May 8, 2018
Completion
May 21, 2019
Last update posted
Oct 7, 2020

2018 – 2019

United States locations

U.S. sites
11
U.S. states
11
U.S. cities
11
Facility City State ZIP Site status
Coastal Clinical Research Inc Mobile Alabama 36608
Empire Clinical Research Pomona California 91767
Advanced Clinical Research Meridian Idaho 83462
Johnson County Clin-Trials Lenexa Kansas 66219
Center for Pharmaceutical Research Kansas City Missouri 64114
Meridian Clinical Research LLC Omaha Nebraska 68134
Regional Clinical Research Inc. Endwell New York 13760
Rapid Medical Research Inc Cleveland Ohio 44122
Tekton Research Austin Texas 78745
Advanced Clinical Research West Jordan Utah 84088
Clinical Research Associates of Tidewater Norfolk Virginia 23507

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03342898, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 7, 2020 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03342898 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →